Maine Biotechnology Services, Inc. is pleased to announce the addition of Dr. Stephen Pelsue as Science Director. Dr. Pelsue is providing technical expertise and leadership to our scientific team as they work to develop and integrate new tools, technologies, and processes that enhance our ability to address challenging new antibody targets on behalf of our client base.
Prior to joining MBS, Dr. Pelsue was an Associate Professor of Immunology & Molecular Biology at the University of Southern Maine, where he ran a research program investigating the development of autoantibodies in autoimmune diseases, particularly focused on Lupus. In addition to his research program he taught molecular biology, biochemistry, genetics, and immunology. He served as Graduate Coordinator and Department Chair in the Department of Applied Medical Sciences, as well as served as the first Associate Dean in the College of Science, Technology, and Health. Dr. Pelsue’s education includes a B.S. in Chemistry from Northland College, a Ph.D. in Biochemistry from North Carolina State University, and a postdoctoral fellowship at The Jackson Laboratory.
“We are excited by the opportunity to leverage Stephen’s extensive knowledge of immunology and his experience directing research programs, to refine antibody development strategies and approaches to successfully accommodate our client’s complex research needs. Stephen’s ability to technically engage with our clients and provide consulting services as part of our MBS Hybridoma Development Team will help to ensure robust project plans and successful outcomes, ” noted Mike Sullivan, V.P. Operations.
Dr. Pelsue joined Maine Biotechnology Services in the spring of 2015 and brings over 20 years of research experience in antibody development to the position.